Literature DB >> 15588885

Quantified relationship between cellular radiosensitivity, DNA repair defects and chromatin relaxation: a study of 19 human tumour cell lines from different origin.

Nicole Chavaudra1, Jean Bourhis, Nicolas Foray.   

Abstract

BACKGROUND AND
PURPOSE: There is still confusion in the choice of the molecular assays to predict the radiation response of human cells. The case of tumours appears to be particularly complex, may be because of their instability and heterogeneity. The aim of this study was to investigate quantitatively the relationships between DNA double-strand breaks (DSB) repair, chromatin relaxation and cellular radiosensitivity. Nineteen human tumour cell lines, representing a large spectrum of radiation responses and tissues, were examined.
MATERIALS AND METHODS: Intrinsic radiosensitivity was quantified with surviving fraction at 2 Gy (SF2) as an endpoint. Standard and modified pulsed-field gel electrophoresis techniques were employed to assess DSB repair rate and chromatin relaxation. A cell-free assay was chosen to estimate DSB repair activity, independently of chromatin impairment. RESULTS AND
CONCLUSIONS: Surviving fraction at 2 Gy (SF2) decreases linearly with the amount of unrepaired DSB and the extent of chromatin relaxation: one additional unrepaired DSB per cell or 1% chromatin decondensation produce a loss of about 1.5% surviving fraction. However, all the cell lines did not obey both correlations, suggesting that DSB repair and chromatin impairments contribute separately to increase the severity of DNA damage involved in cell lethality. Four cell lines groups showing different DSB repair and/or chromatin impairments were defined. Cell lines exhibiting both DSB repair defect and chromatin relaxation are the most radiosensitive.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588885     DOI: 10.1016/j.radonc.2004.07.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

Review 1.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

2.  Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.

Authors:  Antonella Bufacchi; Barbara Nardiello; Roberto Capparella; Luisa Begnozzi
Journal:  Radiat Oncol       Date:  2013-07-04       Impact factor: 3.481

3.  Endoplasmic reticulum stress pathway PERK-eIF2α confers radioresistance in oropharyngeal carcinoma by activating NF-κB.

Authors:  Qiao Qiao; Chaonan Sun; Chuyang Han; Ning Han; Miao Zhang; Guang Li
Journal:  Cancer Sci       Date:  2017-05-31       Impact factor: 6.716

4.  Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.

Authors:  Antonella Conforti; Nadia Starc; Simone Biagini; Luigi Tomao; Angela Pitisci; Mattia Algeri; Pietro Sirleto; Antonio Novelli; Giulia Grisendi; Olivia Candini; Cintia Carella; Massimo Dominici; Franco Locatelli; Maria Ester Bernardo
Journal:  Oncotarget       Date:  2016-11-22

5.  Interleukin-6 production mediated by the IRE1-XBP1 pathway confers radioresistance in human papillomavirus-negative oropharyngeal carcinoma.

Authors:  Xintong Lyu; Miao Zhang; Guangqi Li; Yiru Cai; Guang Li; Qiao Qiao
Journal:  Cancer Sci       Date:  2019-07-03       Impact factor: 6.716

6.  Molecular and cellular response of the most extensively used rodent glioma models to radiation and/or cisplatin.

Authors:  Zuzana Bencokova; Laurianne Pauron; Clément Devic; Aurélie Joubert; Jérôme Gastaldo; Catherine Massart; Jacques Balosso; Nicolas Foray
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.506

7.  A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.

Authors:  Jean-Philippe Foy; Louis Bazire; Sandra Ortiz-Cuaran; Sophie Deneuve; Janice Kielbassa; Emilie Thomas; Alain Viari; Alain Puisieux; Patrick Goudot; Chloé Bertolus; Nicolas Foray; Youlia Kirova; Pierre Verrelle; Pierre Saintigny
Journal:  BMC Med       Date:  2017-09-01       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.